Vaccine Development Journey
The development of the COVID-19 vaccine stands as a monumental achievement in science, igniting hope amid division. Albert recounts the tense moments leading up to the successful trial results, emphasizing the bold decision to invest over two billion dollars without derisking. This all-in approach was driven by the urgency of the pandemic and the desire to make a difference in a time of fear and uncertainty.In this clip
From this podcast

Lex Fridman Podcast
Albert Bourla: Pfizer CEO | Lex Fridman Podcast #249
Related Questions